TEVA — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Teva Pharmaceutical Industries Limited
Healthcare · $30.08
1.0
/10
Avoid
How this score works →
Regime
Bullish
vs SMA200
SMA200 Distance
+23.4%
Above trend
Volatility
Normal
Average premiums
Momentum
Accelerating
Price direction
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical is the world's largest generic drug maker, also selling branded specialty medicines. Moderate beta, no dividend (cut years ago). A turnaround story with reduced debt. CSP premiums are moderate — best for sellers who believe the recovery trajectory holds.
Drug Manufacturers - Specialty & Generic
Market Cap
$35.0B
P/E Ratio
24.9
Beta
0.76
52-Week Range Current: $30.08
$12.47 $37.35
Earnings
2026-04-29
24 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE